ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

59 hedge funds and large institutions have $24.9M invested in Zynerba Pharmaceuticals, Inc in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-3
Holders Change %
-4.84%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
17
Reduced
15
Closed
11
Calls
$215K
Puts
$120K
Net Calls
+$95K
Net Calls Change
-$259K
Name Holding Trade Value Shares
Change
Shares
Change %
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
-$85.8K -29,789 Closed
AG
52
Algert Global
California
-$57K -19,873 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
-$55K -19,000 Closed
XT
54
XTX Topco
Cayman Islands
-$54K -18,711 Closed
Charles Schwab
55
Charles Schwab
California
-$53K -18,093 Closed
PWA
56
PCG Wealth Advisors
Kansas
-$34K -11,900 Closed
JF
57
Jump Financial
Illinois
-$31K -10,693 Closed
SWM
58
Spire Wealth Management
Virginia
-$2K -602 Closed